A phase 1, randomized, placebo-controlled, double-blind, multiple oral dose study of DS-8500a in Japanese healthy male subjects
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Firuglipel (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 26 Mar 2018 Results assessing the pharmacokinetics and safety, published in the Clinical Drug Investigation.
- 22 Sep 2016 New trial record